期刊文献+

血清IL-6、hs-CRP、Lp-PLA2水平检测在急性冠状动脉综合征患者冠状动脉微血管障碍诊断中的应用价值 被引量:2

Application value of detection of serum IL-6, hs-CRP and Lp-PLA2 levels in diagnosis of coronary microvascular disorders in patients with acute coronary syndrome
下载PDF
导出
摘要 目的:探讨血清白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、脂蛋白相关磷脂酶A2(Lp-PLA2)水平检测在急性冠状动脉综合征(ACS)患者冠状动脉微血管障碍(MVD)诊断中的应用价值。方法:回顾性分析2019年10月至2020年8月该院收治的83例ACS患者的临床资料,按是否合并MVD分为ACS合并MVD组21例和ACS未合并MVD组62例,另选取40名同期健康体检者作为对照组。比较三组IL-6、hs-CRP、Lp-PLA2水平,并绘制受试者工作特征曲线(ROC),分析血清IL-6、hs-CRP、Lp-PLA2水平单项及联合检测诊断ACS合并MVD的价值。结果:ACS合并MVD组血清IL-6、hs-CRP、Lp-PLA2水平均高于ACS未合并MVD组和对照组,且ACS未合并MVD组高于对照组,差异有统计学意义(P<0.05);ROC曲线结果分析显示,ACS患者血清IL-6、hs-CRP、Lp-PLA2水平单项及联合检测诊断ACS合并MVD的曲线下面积(AUC)分别为0.812、0.781、0.828、0.878,均具有一定的诊断价值,且联合检测诊断的AUC大于单项检测,诊断价值更理想。结论:ACS合并MVD患者IL-6、hs-CRP、Lp-PLA2水平呈高表达,血清IL-6、hs-CRP、Lp-PLA2水平检测应用于ACS患者MVD诊断具有较高诊断价值。 Objective: To investigate application value of detection of serum interleukin-6(IL-6), high sensitivity C-reactive protein(hs-CRP) and lipoprotein-related phospholipase A2(Lp-PLA2) levels in coronary microvascular disorders(MVD) in patients with acute coronary syndrome(ACS). Methods: The clinical data of 83 ACS patients admitted to our hospital from October 2019 to August 2020 were retrospectively analyzed.According to whether the patients were combined with MVD or not, they were divided into ACS combined with MVD group(21 cases) and ACS combined with non-MVD group(62 cases). Another 40 healthy subjects were selected as control group. The levels of IL-6, hs-CRP and Lp-PLA2were compared among the three groups. The receiver operating characteristic(ROC) curve was plotted, and the values of serum IL-6, hs-CRP and LpPLA2 levels in the diagnosis of ACS complicated with MVD were analyzed. Results: The serum levels of IL-6, hs-CRP and Lp-PLA2 in the ACS combined with MVD group were higher than those in the ACS combined with non-MVD group and the control group, those of the ACS combined with non-MVD group were higher than those of the control group, and the differences were statistically significant(P<0.05). The ROC curve analysis showed that the AUCs of the serum IL-6, hs-CRP and Lp-PLA2 levels in the patients with ACS for the diagnosis of ACS combined with non-MVD were 0.812, 0.781, 0.828, and 0.878, separately, all of which had certain diagnostic value. The AUC of the combined detection was greater than that of single detection, and its diagnostic value was more ideal. Conclusions: The levels of IL-6, hs-CRP and Lp-PLA2 are highly expressed in the patients with ACS complicated with MVD. The detection of serum IL-6, hs-CRP and Lp-PLA2 levels has high diagnostic value in the diagnosis of MVD in the patients with ACS.
作者 林泽强 谭丹 LIN Zeqiang;TAN Dan(Nanhai Hospital of Southern Medical University,Department of Laboratory Medicine,Foshan 528244 Guangdong,China;Nanhai Hospital of Southern Medical University,Department of Pediatrics,Foshan 528244 Guangdong,China)
出处 《中国民康医学》 2022年第11期130-132,共3页 Medical Journal of Chinese People’s Health
基金 广东省佛山市卫生健康局医学科研课题项目(20210361)。
关键词 白细胞介素-6 超敏C反应蛋白 脂蛋白相关磷脂酶A2 急性冠状动脉综合征 冠状动脉微血管障碍 诊断 Interleukin-6 High sensitivity C-reactive protein Lipoprotein-associated phospholipase A2 Acute coronary syndrome Coronary microvascular disorder Diagnosis
  • 相关文献

参考文献15

二级参考文献150

  • 1吕树铮.中国急性冠脉综合征临床实践与指南的差距[J].心血管病学进展,2006,27(3):261-264. 被引量:17
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2072
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2146
  • 4Pokharel Y, Sun W, Polfus LM, etal. Lipoprotein associated hos- pholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study [J].Atherosclerosis, 2015,241(2) :641-648.
  • 5Gu X, Hou J, Yang S,et al. Is lipoprotein-associated phospho- lipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome [J]. Coron Artery Dis, 2014, 25(1):10-15.
  • 6Ostadal P, Vondrakova D, Kruger A, et al. Alteration in lipo- protein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers [J]. Lipids Health Dis,2012, 11:153.
  • 7Holst-Albrechtsen S, Kjaergaard M, Huynh AN, et al. Can lipoprotein-assoeiated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome [J].Curr Cardiol Rev, 2013,9(4) :310-315.
  • 8Xu RX, Zhang Y, Li XL, et al. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease[J]. Clin Chim Acta, 2015, 446:195-200.
  • 9Jabor B, Choi H, Ruel I, et al. Lipoprotein-assoeiated phospho- lipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relation-ship with low-density lipoprotein cholesterol [J].Can J Cardiol, 2013,29(12) :1679-1686.
  • 10Li N, Li S, Yu C, et al. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a com- munity-based cohort [J]. Postgrad Med, 2010,122(4) :200-205.

共引文献731

同被引文献31

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部